Methods for treating a host suffering from a chronic immune disease, e.g., MS or CFS, are provided. In practicing the subject methods, an effective amount of an elastase inhibitory agent, e.g., a β-lactam containing compound, is administered to the host. Also provided are compositions for use in practicing the subject methods.